샘플 요청 목록

 카트 문의
시장보고서
상품코드
1788507

세계의 혈소판 풍부 혈장 시장 : 산업 분석, 시장 규모, 점유율, 성장, 동향 및 예측(2025-2035년)

Platelet-rich Plasma Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
발행일: | 리서치사: Transparency Market Research | 페이지 정보: 영문 224 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

혈소판 풍부 혈장 시장 - 연구 범위

TMR의 조사 보고서 "세계의 혈소판 풍부 혈장 시장"은 2025-2035년의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거와 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2025년을 기준 연도, 2035년을 예측 연도로 하여 2025년부터 2035년까지 전 세계 혈소판 풍부 혈장 시장의 매출과 예측을 제공합니다. 또한, 2025-2035년까지의 세계 혈소판 풍부 혈장 시장의 연평균 성장률(CAGR%)도 제시합니다.

본 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도자료, 관련 문서 등을 참조하여 혈소판 풍부 혈장 시장을 추론했습니다.

시장 현황
시장 규모(2024년) 8,476억 달러
시장 규모(2035년) 23억 달러
CAGR 9.6%

이 보고서는 세계 혈소판 풍부 혈장 시장 경쟁 구도를 조사했습니다. 세계 혈소판 풍부 혈장 시장에서 사업을 운영하는 주요 기업이 확인되었으며, 각 기업은 다양한 속성별로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 개발, SWOT는 이 보고서에 포함된 세계 혈소판 풍부 혈장 시장 기업의 속성입니다.

세계 혈소판 풍부 혈장 시장 보고서가 답변한 주요 질문은 다음과 같습니다.

  • 예측 기간 동안 모든 지역의 아펠레시스 매출/수익은?
  • 세계 혈소판 풍부 혈장 시장에서의 비즈니스 기회는?
  • 시장의 주요 촉진요인, 시장 성장 억제요인, 기회, 위협 요인은 무엇인가?
  • 예측 기간 동안 가장 빠른 CAGR로 성장할 지역 시장은 어디인가?
  • 2035년 세계에서 가장 높은 수익을 창출할 것으로 예상되는 분야는?
  • 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상되는 부문은?
  • 세계 시장에서 사업을 전개하는 각 기업 시장 지위는?

혈소판 풍부 혈장 시장 - 조사 목적 및 조사 방법

세계 혈소판 풍부 혈장 시장에 대한 종합적인 보고서는 개요로 시작하여 연구 범위와 목적이 이어집니다. 본 조사의 목적, 시장에서 사업을 전개하고 있는 주요 벤더와 유통업체, 제품 승인에 관한 규제 시나리오에 대해 상세하게 설명합니다.

본 보고서는 가독성을 고려하여 각 섹션을 장별로 나누어 레이아웃을 구성하였습니다. 본 보고서는 그래프와 표를 적절히 배치한 종합적인 자료로 구성되어 있습니다. 주요 부문의 분석과 예측치를 도식화하여 독자에게 시각적으로 어필합니다. 또한, 과거와 예측 기간 말의 주요 부문별 시장 점유율을 비교할 수 있습니다.

이 보고서는 세계 혈소판 풍부 혈장 시장을 유형, 공급원, 지역별로 분석합니다. 각 기준의 주요 부문을 상세하게 조사하고, 2035년 말 기준 각 부문 시장 점유율을 제공합니다. 이러한 귀중한 통찰력을 통해 시장 이해관계자들은 세계 혈소판 풍부 혈장 시장에 대한 투자에 대한 정보에 입각한 비즈니스 의사결정을 내릴 수 있습니다.

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

  • 서론
  • 개요
  • 시장 역학
  • 세계의 혈소판 풍부 혈장 시장 분석과 예측(2020-2035년)

제5장 주요 인사이트

  • 주요 지역/국가 의료비 지출
  • 혈소판 풍부 혈장 치료 기술 진보
  • 주요 지역/국가 규제 시나리오
  • Porter의 Five Forces 분석
  • PESTEL 분석
  • 밸류체인 분석
  • 최종사용자에 있어서의 주요 구입 지표
  • 신규 시장 참여 사람을 위한 시장 개척 전략
  • 주요 업계 이벤트(파트너십, 협업, 제품 승인, 합병 및 인수)
  • 주요 경쟁이 제공하는 주요 제품 벤치마킹

제6장 세계 시장 분석과 예측 : 유형별(PRP)

  • 서론 및 정의
  • 주요 분석 결과/진전
  • 시장 예측(금액 기준) : 유형별(PRP)(2020-2035년)
    • Pure Platelet-Rich Plasma (P-PRP)
    • Leukocyte-and Platelet-Rich Plasma (L-PRP)
    • Pure Platelet-Rich Fibrin (P-PRF)
    • Leukocyte- and Platelet-Rich Fibrin (L-PRF)
  • 시장의 매력 : 유형별(PRP)

제7장 세계 시장 분석과 예측 : 공급원별

  • 서론 및 정의
  • 주요 분석 결과/진전
  • 시장 예측(금액 기준) : 공급원별(2020-2035년)
    • 자기 PRP
    • 동종 PRP
  • 시장의 매력 : 공급원별

제8장 세계 시장 분석과 예측 : 용도별

  • 서론 및 정의
  • 주요 분석 결과/진전
  • 시장 예측(금액 기준) : 용도별(2020-2035년)
    • 정형외과
      • 관절염
      • 만성건염
      • 뼈 수복 및 재생
    • 스포츠 의학
    • 피부과 및 창상 치유
      • 궤양 치료
        • 정맥 궤양
        • 외상성 궤양
        • 당뇨병성 궤양
        • 혈관염성 궤양
        • 기타
      • 페이셜 회춘
      • 육모
      • 기타
    • 미용성형
    • 안과 수술
    • 뇌신경외과
    • 심장 수술
    • 일반외과
    • 기타
  • 시장의 매력 : 용도별

제9장 세계 시장 분석과 예측 : 최종사용자별

  • 서론 및 정의
  • 주요 분석 결과/진전
  • 시장 예측(금액 기준) : 최종사용자별(2020-2035년)
    • 병원 및 외래수술센터(ASC)
    • 피부과 및 미용 클리닉
    • 치과의원
    • 스포츠 클리닉 및 재활치료센터
    • 기타
  • 시장의 매력 : 최종사용자별

제10장 세계 시장 분석과 예측 : 지역별

  • 주요 분석 결과
  • 시장 예측(금액 기준) : : 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 시장의 매력 : 지역별

제11장 북미 시장 분석과 예측

  • 미국
  • 캐나다

제12장 유럽 시장 분석과 예측

  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 스위스
  • 네덜란드
  • 기타 유럽

제13장 아시아태평양 시장 분석과 예측

  • 중국
  • 인도
  • 일본
  • 한국
  • 호주 및 뉴질랜드
  • 기타 아시아태평양

제14장 라틴아메리카 시장 분석과 예측

  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카

제15장 중동 및 아프리카 시장 분석과 예측

  • GCC 국가
  • 남아프리카공화국
  • 기타 중동 및 아프리카

제16장 경쟁 구도

  • 시장 기업 - 경쟁 매트릭스(기업 Tier별, 규모별)
  • 시장 점유율 분석 기업별(2024년)
  • 기업 개요
    • Johnson & Johnson Services, Inc.
    • Stryker
    • Zimmer Biomet
    • Arthrex, Inc.
    • Terumo BCT, Inc.
    • Crown Aesthetics
    • Celling Biosciences
    • EmCyte Corporation
    • Juventix Regenerative Medical, LLC.
    • APEX Biologix
    • Dr PRP USA LLC
    • Changsha Yingtai Instrument Co., Ltd.
    • Accuquik Test Kits
    • Aspire Medical Innovation
    • Factor Medical, Inc.
LSH 25.08.19

Platelet-rich Plasma Market- Scope of Report

TMR's report on the global Platelet-rich Plasma Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global Platelet-rich Plasma Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Platelet-rich Plasma Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the two-wheeler navigation display market.

Market Snapshot
Market Value in 2024US$ 847.6 Bn
Market Value in 2035US$ 2.3 Bn
CAGR9.6%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global two-wheeler navigation display market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global two-wheeler navigation display market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global two-wheeler navigation display market.

The report delves into the competitive landscape of the global two-wheeler navigation display market. Key players operating in the global Platelet-rich Plasma Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Platelet-rich Plasma Marketprofiled in this report.

Key Questions Answered in Global Platelet-rich Plasma MarketReport:

  • What is the sales/revenue generated by apheresis across all regions during the forecast period?
  • What are the opportunities in the global two-wheeler navigation display market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Platelet-rich Plasma Market- Research Objectives and Research Approach

The comprehensive report on the global Platelet-rich Plasma Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Platelet-rich Plasma Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global two-wheeler navigation display market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Platelet-rich Plasma Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Platelet-rich Plasma Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Healthcare Expenditure across Key Regions / Countries
  • 5.2. Technological Advancements in Platelet-rich Plasma Treatment
  • 5.3. Regulatory Scenario across Key Regions / Countries
  • 5.4. PORTER's Five Forces Analysis
  • 5.5. PESTEL Analysis
  • 5.6. Value Chain Analysis
  • 5.7. Key Purchase Metrics for End-users
  • 5.8. Go-to-Market Strategy for New Market Entrants
  • 5.9. Key Industry Events (Partnerships, Collaborations, Product approvals, mergers & acquisitions)
  • 5.10. Benchmarking of Key Products Offered by the Leading Competitors

6. Global Platelet-rich Plasma Market Analysis and Forecasts, By Type of Platelet-rich Plasma (PRP)

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type of Platelet-rich Plasma (PRP), 2020 to 2035
    • 6.3.1. Pure Platelet-Rich Plasma (P-PRP)
    • 6.3.2. Leukocyte-and Platelet-Rich Plasma (L-PRP)
    • 6.3.3. Pure Platelet-Rich Fibrin (P-PRF)
    • 6.3.4. Leukocyte- and Platelet-Rich Fibrin (L-PRF)
  • 6.4. Market Attractiveness By Type of Platelet-rich Plasma (PRP)

7. Global Platelet-rich Plasma Market Analysis and Forecasts, By Source

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Source, 2020 to 2035
    • 7.3.1. Autologous PRP
    • 7.3.2. Allogenic PRP
  • 7.4. Market Attractiveness By Source

8. Global Platelet-rich Plasma Market Analysis and Forecasts, By Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Application, 2020 to 2035
    • 8.3.1. Orthopedics
      • 8.3.1.1. Arthritis
      • 8.3.1.2. Chronic Tendinitis
      • 8.3.1.3. Bone Repair and Regeneration
    • 8.3.2. Sports Medicine
    • 8.3.3. Dermatology / Wound Healing
      • 8.3.3.1. Ulcer Healing
        • 8.3.3.1.1. Venous Ulcer
        • 8.3.3.1.2. Traumatic Ulcer
        • 8.3.3.1.3. Diabetic Ulcer
        • 8.3.3.1.4. Vasculitic Ulcer
        • 8.3.3.1.5. Others
      • 8.3.3.2. Facial Rejuvenation
      • 8.3.3.3. Hair Restoration
      • 8.3.3.4. Others
    • 8.3.4. Cosmetic Surgery
    • 8.3.5. Ophthalmic Surgery
    • 8.3.6. Neurosurgery
    • 8.3.7. Cardiac Surgery
    • 8.3.8. General Surgery
    • 8.3.9. Others
  • 8.4. Market Attractiveness By Application

9. Global Platelet-rich Plasma Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2020 to 2035
    • 9.3.1. Hospitals and Ambulatory Surgical Centers
    • 9.3.2. Dermatology and Aesthetic Clinics
    • 9.3.3. Dental Clinics
    • 9.3.4. Sport Clinics and Rehabilitation Centers
    • 9.3.5. Others
  • 9.4. Market Attractiveness By End-user

10. Global Platelet-rich Plasma Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Platelet-rich Plasma Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type of Platelet-rich Plasma (PRP), 2020 to 2035
    • 11.2.1. Pure Platelet-Rich Plasma (P-PRP)
    • 11.2.2. Leukocyte-and Platelet-Rich Plasma (L-PRP)
    • 11.2.3. Pure Platelet-Rich Fibrin (P-PRF)
    • 11.2.4. Leukocyte- and Platelet-Rich Fibrin (L-PRF)
  • 11.3. Market Value Forecast By Source, 2020 to 2035
    • 11.3.1. Autologous PRP
    • 11.3.2. Allogenic PRP
  • 11.4. Market Value Forecast By Application, 2020 to 2035
    • 11.4.1. Orthopedics
      • 11.4.1.1. Arthritis
      • 11.4.1.2. Chronic Tendinitis
      • 11.4.1.3. Bone Repair and Regeneration
    • 11.4.2. Sports Medicine
    • 11.4.3. Dermatology / Wound Healing
      • 11.4.3.1. Ulcer Healing
        • 11.4.3.1.1. Venous Ulcer
        • 11.4.3.1.2. Traumatic Ulcer
        • 11.4.3.1.3. Diabetic Ulcer
        • 11.4.3.1.4. Vasculitic Ulcer
        • 11.4.3.1.5. Others
      • 11.4.3.2. Facial Rejuvenation
      • 11.4.3.3. Hair Restoration
      • 11.4.3.4. Others
    • 11.4.4. Cosmetic Surgery
    • 11.4.5. Ophthalmic Surgery
    • 11.4.6. Neurosurgery
    • 11.4.7. Cardiac Surgery
    • 11.4.8. General Surgery
    • 11.4.9. Others
  • 11.5. Market Value Forecast By End-user, 2020 to 2035
    • 11.5.1. Hospitals and Ambulatory Surgical Centers
    • 11.5.2. Dermatology and Aesthetic Clinics
    • 11.5.3. Dental Clinics
    • 11.5.4. Sport Clinics and Rehabilitation Centers
    • 11.5.5. Others
  • 11.6. Market Value Forecast By Country, 2020 to 2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Type of Platelet-rich Plasma (PRP)
    • 11.7.2. By Source
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Platelet-rich Plasma Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type of Platelet-rich Plasma (PRP), 2020 to 2035
    • 12.2.1. Pure Platelet-Rich Plasma (P-PRP)
    • 12.2.2. Leukocyte-and Platelet-Rich Plasma (L-PRP)
    • 12.2.3. Pure Platelet-Rich Fibrin (P-PRF)
    • 12.2.4. Leukocyte- and Platelet-Rich Fibrin (L-PRF)
  • 12.3. Market Value Forecast By Source, 2020 to 2035
    • 12.3.1. Autologous PRP
    • 12.3.2. Allogenic PRP
  • 12.4. Market Value Forecast By Application, 2020 to 2035
    • 12.4.1. Orthopedics
      • 12.4.1.1. Arthritis
      • 12.4.1.2. Chronic Tendinitis
      • 12.4.1.3. Bone Repair and Regeneration
    • 12.4.2. Sports Medicine
    • 12.4.3. Dermatology / Wound Healing
      • 12.4.3.1. Ulcer Healing
        • 12.4.3.1.1. Venous Ulcer
        • 12.4.3.1.2. Traumatic Ulcer
        • 12.4.3.1.3. Diabetic Ulcer
        • 12.4.3.1.4. Vasculitic Ulcer
        • 12.4.3.1.5. Others
      • 12.4.3.2. Facial Rejuvenation
      • 12.4.3.3. Hair Restoration
      • 12.4.3.4. Others
    • 12.4.4. Cosmetic Surgery
    • 12.4.5. Ophthalmic Surgery
    • 12.4.6. Neurosurgery
    • 12.4.7. Cardiac Surgery
    • 12.4.8. General Surgery
    • 12.4.9. Others
  • 12.5. Market Value Forecast By End-user, 2020 to 2035
    • 12.5.1. Hospitals and Ambulatory Surgical Centers
    • 12.5.2. Dermatology and Aesthetic Clinics
    • 12.5.3. Dental Clinics
    • 12.5.4. Sport Clinics and Rehabilitation Centers
    • 12.5.5. Others
  • 12.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 12.6.1. Germany
    • 12.6.2. UK
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Switzerland
    • 12.6.7. The Netherlands
    • 12.6.8. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Type of Platelet-rich Plasma (PRP)
    • 12.7.2. By Source
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country / Sub-region

13. Asia Pacific Platelet-rich Plasma Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type of Platelet-rich Plasma (PRP), 2020 to 2035
    • 13.2.1. Pure Platelet-Rich Plasma (P-PRP)
    • 13.2.2. Leukocyte-and Platelet-Rich Plasma (L-PRP)
    • 13.2.3. Pure Platelet-Rich Fibrin (P-PRF)
    • 13.2.4. Leukocyte- and Platelet-Rich Fibrin (L-PRF)
  • 13.3. Market Value Forecast By Source, 2020 to 2035
    • 13.3.1. Autologous PRP
    • 13.3.2. Allogenic PRP
  • 13.4. Market Value Forecast By Application, 2020 to 2035
    • 13.4.1. Orthopedics
      • 13.4.1.1. Arthritis
      • 13.4.1.2. Chronic Tendinitis
      • 13.4.1.3. Bone Repair and Regeneration
    • 13.4.2. Sports Medicine
    • 13.4.3. Dermatology / Wound Healing
      • 13.4.3.1. Ulcer Healing
        • 13.4.3.1.1. Venous Ulcer
        • 13.4.3.1.2. Traumatic Ulcer
        • 13.4.3.1.3. Diabetic Ulcer
        • 13.4.3.1.4. Vasculitic Ulcer
        • 13.4.3.1.5. Others
      • 13.4.3.2. Facial Rejuvenation
      • 13.4.3.3. Hair Restoration
      • 13.4.3.4. Others
    • 13.4.4. Cosmetic Surgery
    • 13.4.5. Ophthalmic Surgery
    • 13.4.6. Neurosurgery
    • 13.4.7. Cardiac Surgery
    • 13.4.8. General Surgery
    • 13.4.9. Others
  • 13.5. Market Value Forecast By End-user, 2020 to 2035
    • 13.5.1. Hospitals and Ambulatory Surgical Centers
    • 13.5.2. Dermatology and Aesthetic Clinics
    • 13.5.3. Dental Clinics
    • 13.5.4. Sport Clinics and Rehabilitation Centers
    • 13.5.5. Others
  • 13.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. South Korea
    • 13.6.5. Australia & New Zealand
    • 13.6.6. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Type of Platelet-rich Plasma (PRP)
    • 13.7.2. By Source
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country / Sub-region

14. Latin America Platelet-rich Plasma Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type of Platelet-rich Plasma (PRP), 2020 to 2035
    • 14.2.1. Pure Platelet-Rich Plasma (P-PRP)
    • 14.2.2. Leukocyte-and Platelet-Rich Plasma (L-PRP)
    • 14.2.3. Pure Platelet-Rich Fibrin (P-PRF)
    • 14.2.4. Leukocyte- and Platelet-Rich Fibrin (L-PRF)
  • 14.3. Market Value Forecast By Source, 2020 to 2035
    • 14.3.1. Autologous PRP
    • 14.3.2. Allogenic PRP
  • 14.4. Market Value Forecast By Application, 2020 to 2035
    • 14.4.1. Orthopedics
      • 14.4.1.1. Arthritis
      • 14.4.1.2. Chronic Tendinitis
      • 14.4.1.3. Bone Repair and Regeneration
    • 14.4.2. Sports Medicine
    • 14.4.3. Dermatology / Wound Healing
      • 14.4.3.1. Ulcer Healing
        • 14.4.3.1.1. Venous Ulcer
        • 14.4.3.1.2. Traumatic Ulcer
        • 14.4.3.1.3. Diabetic Ulcer
        • 14.4.3.1.4. Vasculitic Ulcer
        • 14.4.3.1.5. Others
      • 14.4.3.2. Facial Rejuvenation
      • 14.4.3.3. Hair Restoration
      • 14.4.3.4. Others
    • 14.4.4. Cosmetic Surgery
    • 14.4.5. Ophthalmic Surgery
    • 14.4.6. Neurosurgery
    • 14.4.7. Cardiac Surgery
    • 14.4.8. General Surgery
    • 14.4.9. Others
  • 14.5. Market Value Forecast By End-user, 2020 to 2035
    • 14.5.1. Hospitals and Ambulatory Surgical Centers
    • 14.5.2. Dermatology and Aesthetic Clinics
    • 14.5.3. Dental Clinics
    • 14.5.4. Sport Clinics and Rehabilitation Centers
    • 14.5.5. Others
  • 14.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Argentina
    • 14.6.4. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Type of Platelet-rich Plasma (PRP)
    • 14.7.2. By Source
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country / Sub-region

15. Middle East & Africa Platelet-rich Plasma Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Type of Platelet-rich Plasma (PRP), 2020 to 2035
    • 15.2.1. Pure Platelet-Rich Plasma (P-PRP)
    • 15.2.2. Leukocyte-and Platelet-Rich Plasma (L-PRP)
    • 15.2.3. Pure Platelet-Rich Fibrin (P-PRF)
    • 15.2.4. Leukocyte- and Platelet-Rich Fibrin (L-PRF)
  • 15.3. Market Value Forecast By Source, 2020 to 2035
    • 15.3.1. Autologous PRP
    • 15.3.2. Allogenic PRP
  • 15.4. Market Value Forecast By Application, 2020 to 2035
    • 15.4.1. Orthopedics
      • 15.4.1.1. Arthritis
      • 15.4.1.2. Chronic Tendinitis
      • 15.4.1.3. Bone Repair and Regeneration
    • 15.4.2. Sports Medicine
    • 15.4.3. Dermatology / Wound Healing
      • 15.4.3.1. Ulcer Healing
        • 15.4.3.1.1. Venous Ulcer
        • 15.4.3.1.2. Traumatic Ulcer
        • 15.4.3.1.3. Diabetic Ulcer
        • 15.4.3.1.4. Vasculitic Ulcer
        • 15.4.3.1.5. Others
      • 15.4.3.2. Facial Rejuvenation
      • 15.4.3.3. Hair Restoration
      • 15.4.3.4. Others
    • 15.4.4. Cosmetic Surgery
    • 15.4.5. Ophthalmic Surgery
    • 15.4.6. Neurosurgery
    • 15.4.7. Cardiac Surgery
    • 15.4.8. General Surgery
    • 15.4.9. Others
  • 15.5. Market Value Forecast By End-user, 2020 to 2035
    • 15.5.1. Hospitals and Ambulatory Surgical Centers
    • 15.5.2. Dermatology and Aesthetic Clinics
    • 15.5.3. Dental Clinics
    • 15.5.4. Sport Clinics and Rehabilitation Centers
    • 15.5.5. Others
  • 15.6. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Type of Platelet-rich Plasma (PRP)
    • 15.7.2. By Source
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country / Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis By Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. Johnson & Johnson Services, Inc.
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. Stryker
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. Zimmer Biomet
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. Arthrex, Inc.
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. Terumo BCT, Inc.
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. Crown Aesthetics
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. Celling Biosciences
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. EmCyte Corporation
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. Juventix Regenerative Medical, LLC.
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. APEX Biologix
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. Dr PRP USA LLC
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Product Portfolio
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. Changsha Yingtai Instrument Co., Ltd.
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Product Portfolio
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments
    • 16.3.13. Accuquik Test Kits
      • 16.3.13.1. Company Overview
      • 16.3.13.2. Financial Overview
      • 16.3.13.3. Product Portfolio
      • 16.3.13.4. Business Strategies
      • 16.3.13.5. Recent Developments
    • 16.3.14. Aspire Medical Innovation
      • 16.3.14.1. Company Overview
      • 16.3.14.2. Financial Overview
      • 16.3.14.3. Product Portfolio
      • 16.3.14.4. Business Strategies
      • 16.3.14.5. Recent Developments
    • 16.3.15. Factor Medical, Inc.
      • 16.3.15.1. Company Overview
      • 16.3.15.2. Financial Overview
      • 16.3.15.3. Product Portfolio
      • 16.3.15.4. Business Strategies
      • 16.3.15.5. Recent Developments
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제